Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | POLB | P06746 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | NQO2 | P16083 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | THRB | P10828 | 2/20 | 0.45 |
| ▸ | BLM | P54132 | 2/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.45 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9297195 | 0.86 | TYR (0.43) | KDM4EALDH1A1RAB9AMEN1POLB | |
| SCHEMBL926786 | 0.85 | ALDH1A1 (0.48) | KDM4EALDH1A1RAB9AMEN1POLB | |
| SCHEMBL29475990 | 0.85 | ALDH1A1 (0.48) | KDM4EALDH1A1RAB9AMEN1POLB | |
| SCHEMBL31637723 | 0.83 | RAB9A (0.39) | KDM4EALDH1A1RAB9AMEN1POLB | |
| SCHEMBL8975216 | 0.81 | KMT2A (0.47) | KDM4EALDH1A1RAB9AMEN1KMT2A | |
| SCHEMBL27394057 | 0.78 | HPGD (0.47) | KDM4EALDH1A1RAB9AMEN1POLB | |
| SCHEMBL27563412 | 0.78 | KDM4E (0.49) | KDM4EALDH1A1RAB9APOLBSMN1; SMN2 | |
| SCHEMBL28056200 | 0.77 | NPC1 (0.43) | RAB9AMEN1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL29802293 | 0.76 | RAB9A (0.71) | KDM4ERAB9AMEN1POLBKMT2A | |
| SCHEMBL26932219 | 0.76 | RAB9A (0.71) | KDM4ERAB9AMEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 808 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117562064-A | Application of 6-methoxybenzoxazolin-2-one in inhibiting soil-borne pathogenic bacteria of broad beans | 云南农业大学 | 2024-02-20 | — | — | CN | claimed |
| CN-115644186-A | Application of 6-methoxy-benzoxazoline-2-ketone in trapping meloidogyne incognita | 浙江大学 | 2023-01-31 | — | — | CN | claimed |
| US-7091360-B2 | Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses thereof | AVENTIS PHARMA S.A. (US) | 2006-08-15 | — | — | US | claimed |
| EP-1495007-A4 | PROCESS FOR PREPARING HETEROARYL AND UNSATURATED HETEROCYCLOALKYLMAGNESIUM REAGENTS AND USES | AXYS PHARM INC (US) | 2006-05-03 | — | — | EP | claimed |
| EP-1495007-A1 | PROCESS FOR PREPARING HETEROARYL AND UNSATURATED HETEROCYCLOALKYLMAGNESIUM REAGENTS AND USES | AXYS PHARMACEUTICALS, INC. (US) | 2005-01-12 | — | — | EP | claimed |
| US-20040019218-A1 | Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses thereof | AXYS PHARMACEUTICALS, INC. | 2004-01-29 | — | — | US | claimed |
| WO-2003087068-A1 | PROCESS FOR PREPARING HETEROARYL AND UNSATURATED HETEROCYCLOALKYLMAGNESIUM REAGENTS AND USES | AXYS PHARMACEUTICALS, INC. (US) | 2003-10-23 | — | — | WO | claimed |
| EP-0278509-B1 | Silver halide photographic emulsion | FUJI PHOTO FILM CO LTD (JP) | 1996-01-24 | — | — | EP | claimed |
| EP-0368327-B1 | Light-sensitive composition | FUJI PHOTO FILM CO LTD (JP) | 1995-02-15 | — | — | EP | claimed |
| EP-0271260-B1 | Supersensitization of silver halide emulsions | MINNESOTA MINING & MFG (US) | 1995-01-04 | — | — | EP | claimed |
| US-4970141-A | ELEVATED SPECTRAL SENSITIVITY IN GREEN WAVELENGTH REGION | FUJI PHOTO FILM CO., LTD. (JP) | 1990-11-13 | — | — | US | claimed |
| EP-0368327-A2 | Light-sensitive composition | FUJI PHOTO FILM CO., LTD. (JP) | 1990-05-16 | — | — | EP | claimed |
| US-4891305-A | LASERS | RICOH CO., LTD. (JP) | 1990-01-02 | — | — | US | claimed |
| US-4889796-A | CONTAINING BENZOXAZOLE COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1989-12-26 | — | — | US | claimed |
| US-4873184-A | ADDITION OF A METAL COMPLEXING AGENT TO THE EMULSION; HIGH SPEED | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-10-10 | — | — | US | claimed |
| EP-0278509-A2 | Silver halide photographic emulsion | FUJI PHOTO FILM CO., LTD. (JP) | 1988-08-17 | — | — | EP | claimed |
| EP-0271260-A2 | Supersensitization of silver halide emulsions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1988-06-15 | — | — | EP | claimed |
| US-4154616-A | BENZOXAZOLE OR NAPHTHOXAZOLE MEROCYANINE DYE | FUJI PHOTO FILM CO., LTD. (JP) | 1979-05-15 | — | — | US | claimed |
| US-4057430-A | MEROCYANINE THIOHYDANTOIN SENSITIZERS | FUJI PHOTO FILM CO., LTD. (JA) | 1977-11-08 | — | — | US | claimed |
| US-3970461-A | Fogged, direct-positive silver halide emulsion containing carbocyanine dye having indolenine nucleus | FUJI PHOTO FILM CO., LTD. (JA) | 1976-07-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040019218-A1 | Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses thereof | SPINT2, CTSV, CTSZ | KDM4E 4252/4885ALDH1A1 2466/4885RAB9A 3107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.